bpc-157 pharmacokinetics half-life study The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 and the gut–brain axis:
Description
That difference is absolute
To understand how these substances may affect the body, well need rigorous clinical trials studying individual peptides, experts say
Thank you for the great work you do
International Journal of Obesity and Related Metabolic Disorders
